documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
711 rows where agency_id = "FDA" and posted_year = 2002 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Notice 521
- Other 154
- Supporting & Related Material 15
- Rule 14
- Proposed Rule 7
posted_year 1
- 2002 · 711 ✖
agency_id 1
- FDA · 711 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1992-V-0009-0001 | FDA | Laser Light Show - CLOSED FDA-1992-V-0009 | Variance Approval from FDA CDRH to Jeff Cone Studios | Other | Approval for Variance (VRA) | 2002-12-31T05:00:00Z | 2002 | 12 | 2015-09-25T18:13:35Z | 0 | 0 | 0900006480525e3b | |||
| FDA-2002-N-0098-0003 | FDA | Emergency Med. Device Shortage Program Survey;Agency Informa FDA-2002-N-0098 | Agency Information Collection Activities; Proposed Collection; Comment Request; Emergency Medical Device Shortage Program Survey | Notice | General Notice | 2002-12-30T05:00:00Z | 2002 | 12 | 2002-12-30T05:00:00Z | 2003-03-01T04:59:59Z | 2025-04-25T16:48:02Z | 02-32850 | 0 | 0 | 090000648048e7a6 |
| FDA-2001-P-0084-0001 | FDA | ANDA suitability for Diazepam Injection Auto-Injector FDA-2001-P-0084 | FDA | Notice | N-Notice | 2002-12-30T05:00:00Z | 2002 | 12 | 2024-09-11T17:38:12Z | 67FR79640 | 0 | 0 | 09000064804b8464 | ||
| FDA-2002-N-0314-0001 | FDA | Request for Samples and Protocols FDA-2002-N-0314 | Agency Information Collection Activities; Proposed Collection; Comment Request; Request for Samples and Protocols | Notice | 60 Day Proposed Information Collection | 2002-12-30T00:00:00Z | 2002 | 12 | 2002-12-27T05:00:00Z | 2003-02-26T04:59:59Z | 2025-05-13T17:10:39Z | 02-32749 | 0 | 0 | 090000648049fbad |
| FDA-2002-N-0028-0001 | FDA | Irradiation in the production,processing & handling of food FDA-2002-N-0028 | Agency Information Collection Activities; Proposed Collection; Comment Request; Irradiation in the Production, Processing, and Handling of Food | Notice | General Notice | 2002-12-29T05:00:00Z | 2002 | 12 | 2002-12-27T05:00:00Z | 2003-02-26T04:59:59Z | 2025-05-13T16:58:08Z | 02-32662 | 0 | 0 | 090000648048930a |
| FDA-2002-N-0151-0002 | FDA | Agency Info. Collection Activities;Notices of Participation FDA-2002-N-0151 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; Notice of Participation | Notice | General Notice | 2002-12-29T05:00:00Z | 2002 | 12 | 2002-12-30T05:00:00Z | 2003-01-30T04:59:59Z | 2025-05-08T16:21:48Z | 02-32849 | 0 | 0 | 09000064804929ab |
| FDA-2002-D-0008-0001 | FDA | Health Claims labeling conventional foods/dietary supplement FDA-2002-D-0008 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-27T05:00:00Z | 2002 | 12 | 2008-04-12T01:16:05Z | 0 | 0 | 09000064804874c9 | |||
| FDA-1999-N-0085-0001 | FDA | Withdrawal of Approval of 1 NDA & 38 ANDAs FDA-1999-N-0085 | SoloPak Laboratories, Inc.; Withdrawal of Approval of 1 New Drug Application and 38 Abbreviated New Drug Applications; Correction | Notice | Correction | 2002-12-26T05:00:00Z | 2002 | 12 | 2025-03-18T17:26:37Z | 02-32161 | 0 | 0 | 09000064804a6a3d | ||
| FDA-2002-N-0152-0004 | FDA | Consumer Surveys on Food & Dietary Supplement Labeling FDA-2002-N-0152 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; Consumer Surveys on Food and Dietary Supplement Labeling Issues | Notice | General Notice | 2002-12-26T05:00:00Z | 2002 | 12 | 2002-12-23T05:00:00Z | 2003-01-23T04:59:59Z | 2025-04-25T14:55:56Z | 02-32160 | 0 | 0 | 0900006480492af2 |
| FDA-2001-P-0028-0002 | FDA | Salad Dressing Deviating FDA-2001-P-0028 | Notice of Temporary Permit for Kraft Foods, Inc. | Notice | Notice of Temporary Permit | 2002-12-23T05:00:00Z | 2002 | 12 | 2024-08-23T15:05:38Z | 0 | 0 | 09000064804b5dff | |||
| FDA-1999-P-0001-0001 | FDA | Reclassification and Codification of Absorbable Polydioxanone Surgical Suture FDA-1999-P-0001 | Medical Devices; Reclassification and Codification of the Absorbable Polydioxanone Surgical Suture | Rule | Final Rule | 2002-12-23T05:00:00Z | 2002 | 12 | 2002-12-19T05:00:00Z | 2003-01-22T04:59:59Z | 2017-07-18T19:22:51Z | 02–31993 | 0 | 0 | 09000064804a58ba |
| FDA-1998-N-0008-0002 | FDA | Bioavailability and Bioequivalence Requirements - CLOSED FDA-1998-N-0008 | Bioavailability and Bioequivalence Requirements; Abbreviated Applications; Final Rule | Rule | Final Rule | 2002-12-23T05:00:00Z | 2002 | 12 | 2024-09-27T15:54:49Z | 2002-31996 | 0 | 0 | 0900006480558df9 | ||
| FDA-2002-D-0179-0002 | FDA | Surgical Sutures FDA-2002-D-0179 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-23T05:00:00Z | 2002 | 12 | 2002-12-23T05:00:00Z | 2003-03-20T04:59:59Z | 2008-04-12T01:17:16Z | 0 | 0 | 09000064804951cb | |
| FDA-2002-P-0251-0004 | FDA | Determine if Phenergan has been withdrawn or withheld from s FDA-2002-P-0251 | FDA | Notice | N-Notice | 2002-12-23T05:00:00Z | 2002 | 12 | 2008-04-12T01:27:49Z | 0 | 0 | 090000648049bea4 | |||
| FDA-2002-D-0148-0001 | FDA | Manufacture and Labeling of Raw Meat Foods FDA-2002-D-0148 | Draft Guidance for Industry on the Manufacture and Labeling of Raw Meat Foods for Companion and Captive Noncompanion Carnivores and Omnivores; Availability | Notice | NAD-Notice of Availability of Data | 2002-12-23T05:00:00Z | 2002 | 12 | 2002-12-23T05:00:00Z | 2003-03-04T04:59:59Z | 2010-12-21T22:32:48Z | 0 | 0 | 09000064804925f7 | |
| FDA-2002-D-0179-0001 | FDA | Surgical Sutures FDA-2002-D-0179 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-23T05:00:00Z | 2002 | 12 | 2002-12-23T05:00:00Z | 2003-03-20T04:59:59Z | 2008-04-12T01:17:16Z | 0 | 0 | 09000064804951b2 | |
| FDA-2002-N-0029-0001 | FDA | Large & Small Volume Parenterals Used in Total Parenteral Nu FDA-2002-N-0029 | Agency Information Collection Activities; Proposed Collection; Comment Request; Aluminum in Large and Small Volume Parenterals Used in Total Parenteral Nutrition | Notice | General Notice | 2002-12-22T05:00:00Z | 2002 | 12 | 2002-12-19T05:00:00Z | 2003-02-19T04:59:59Z | 2025-05-13T15:22:30Z | 02-31995 | 0 | 0 | 09000064804893cc |
| FDA-2002-N-0312-0002 | FDA | General Administrative Procedures Petition reconsideration FDA-2002-N-0312 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions | Notice | General Notice | 2002-12-22T05:00:00Z | 2002 | 12 | 2002-12-18T05:00:00Z | 2003-01-18T04:59:59Z | 2025-05-07T23:37:58Z | 02-31722 | 0 | 0 | 090000648049fb58 |
| FDA-2002-N-0238-0001 | FDA | Special Control for Eight Surgical Suture FDA-2002-N-0238 | Medical Devices; Designation of Special Control for Eight Surgical Suture Devices | Notice | NPR-Notice of Proposed Rule-Making | 2002-12-22T05:00:00Z | 2002 | 12 | 2002-12-19T05:00:00Z | 2003-03-20T04:59:59Z | 2025-05-08T18:29:22Z | 02-31991 | 0 | 0 | 090000648049a252 |
| FDA-2001-P-0214-0002 | FDA | Magnification Devices FDA-2001-P-0214 | FDA/CDER to Veigh Hogan | Other | LET-Letter | 2002-12-20T05:00:00Z | 2002 | 12 | 2008-04-25T02:37:12Z | 0 | 0 | 09000064804e474d | |||
| FDA-2002-P-0251-0003 | FDA | Determine if Phenergan has been withdrawn or withheld from s FDA-2002-P-0251 | FDA/CDER to PharmaForce, Inc. | Other | LET-Letter | 2002-12-20T05:00:00Z | 2002 | 12 | 2008-04-12T01:27:49Z | 0 | 0 | 090000648049bea0 | |||
| FDA-2000-N-0110-0001 | FDA | Proposal to Debar Bruce I Diamond PhD, Opportunity for Heari FDA-2000-N-0110 | FDA to Bruce I Diamond PhD - Proposal to Debar/Notice of Opportunity for Hearing | Notice | NPH-Notice of Opportunity of Hearing | 2002-12-19T05:00:00Z | 2002 | 12 | 2008-09-16T16:30:18Z | 0 | 0 | 09000064804ce234 | |||
| FDA-2000-N-0225-0001 | FDA | Proposal to Debar Richard L Borison, Opportunity for Hearing FDA-2000-N-0225 | Proposal to Debar and Notice of Opportunity for Hearing Letter from FDA CDER to Richard L. Borison | Notice | Notice of Opportunity of Hearing | 2002-12-19T05:00:00Z | 2002 | 12 | 2024-12-04T03:48:42Z | 0 | 0 | 09000064804d543a | |||
| FDA-1996-P-0008-0001 | FDA | Reclassify Arrhythmia Detector and Alarm FDA-1996-P-0008 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 2002-12-17T05:00:00Z | 2002 | 12 | 2002-12-13T05:00:00Z | 2003-03-14T04:59:59Z | 2008-05-16T22:19:29Z | 0 | 0 | 09000064804f99fe | |
| FDA-2001-D-0060-0001 | FDA | Class II Special Controls Guidance Cutaneous Carbon Dioxide FDA-2001-D-0060 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-17T05:00:00Z | 2002 | 12 | 2008-04-25T01:57:40Z | 0 | 0 | 09000064804b807c | |||
| FDA-2002-D-0052-0001 | FDA | Arrhythmia Detector and Alarm from class III to class II FDA-2002-D-0052 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-17T05:00:00Z | 2002 | 12 | 2002-12-13T05:00:00Z | 2003-03-14T04:59:59Z | 2008-04-12T01:16:15Z | 0 | 0 | 090000648048b8c9 | |
| FDA-2001-N-0231-0002 | FDA | Reclassification the cutaneous carbon dioxide cutaneous oxy FDA-2001-N-0231 | Medical Devices; Reclassification of the Cutaneous Carbon Dioxide and the Cutaneous Oxygen Monitor | Notice | Notice of Final Rule | 2002-12-17T05:00:00Z | 2002 | 12 | 2025-02-10T16:31:24Z | 02-31442 | 0 | 0 | 09000064804e5f44 | ||
| FDA-2002-P-0077-0002 | FDA | Abbreviated new animal drug applicationIvermectin for cats-CLOSED FDA-2002-P-0077 | FDA/CVM to Highland VetPharma, LLC. | Other | PAV-Petition Approval | 2002-12-16T05:00:00Z | 2002 | 12 | 2008-04-12T01:26:24Z | 0 | 0 | 090000648048d32f | |||
| FDA-2002-P-0170-0002 | FDA | Suitability Petition for Ivermectin Soft-Chew Anthelmintic-CLOSED FDA-2002-P-0170 | FDA/CVM to Intervet Inc. | Other | PAV-Petition Approval | 2002-12-16T05:00:00Z | 2002 | 12 | 2008-04-12T01:26:57Z | 0 | 0 | 09000064804949b6 | |||
| FDA-2002-P-0297-0002 | FDA | ANADA dosage form which differs for Ivermectin Equalan Paste-CLOSED FDA-2002-P-0297 | FDA/CVM to Highland VetPharma, LLC | Other | PAV-Petition Approval | 2002-12-16T05:00:00Z | 2002 | 12 | 2008-04-12T01:28:08Z | 0 | 0 | 090000648049f202 | |||
| FDA-2002-P-0005-0002 | FDA | ANADA for ivermectin/pyrantel different dosage form-CLOSED FDA-2002-P-0005 | FDA/CVM to Highland VetPharma, LLC | Other | PAV-Petition Approval | 2002-12-16T05:00:00Z | 2002 | 12 | 2008-04-12T01:25:47Z | 0 | 0 | 0900006480487280 | |||
| FDA-2002-P-0210-0001 | FDA | Use of Implied Nutrient Content Claim - "Carbolite"-CLOSED FDA-2002-P-0210 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-13T05:00:00Z | 2002 | 12 | 2002-12-13T05:00:00Z | 2003-01-09T04:59:59Z | 2008-04-12T01:27:06Z | 0 | 0 | 09000064804965d7 | |
| FDA-2000-P-0063-0001 | FDA | Cosmetic Products Containing Alpha Hydroxy Acids FDA-2000-P-0063 | Guidance for lndustry: Guidance for lndustry: Labeling for Topically Applied Cosmetic Products Containing Alpha Hydroxy Acids as Ingredients; Availability | Notice | NAD-Notice of Availability of Data | 2002-12-12T05:00:00Z | 2002 | 12 | 2002-12-12T05:00:00Z | 2003-02-01T04:59:59Z | 2013-05-20T02:02:33Z | 0 | 0 | 09000064804af91c | |
| FDA-2002-P-0046-0001 | FDA | Health Claim: D-tagatose and Noncariogenicity - CLOSED FDA-2002-P-0046 | Food Labeling: Health Claims; D-tagatose and Dental Caries; Interim Final Rule | Rule | Interim Final Rule | 2002-12-12T05:00:00Z | 2002 | 12 | 2002-12-02T05:00:00Z | 2003-02-19T04:59:59Z | 2015-12-02T22:01:14Z | 0 | 0 | 090000648048b7f1 | |
| FDA-2000-N-0045-0001 | FDA | Proposal to Debar Laverne M. Charpentier;Notice of Opportuni FDA-2000-N-0045 | Laverne M. Charpentier; Final Debarment Order | Notice | N-Notice | 2002-12-12T05:00:00Z | 2002 | 12 | 2002-12-02T05:00:00Z | 2025-06-13T00:13:30Z | 02-30482 | 0 | 0 | 09000064804af143 | |
| FDA-2000-N-0045-0002 | FDA | Proposal to Debar Laverne M. Charpentier;Notice of Opportuni FDA-2000-N-0045 | Duplicate FR | Notice | 2002-12-12T00:00:00Z | 2002 | 12 | 2024-12-03T22:23:36Z | 0 | 1 | 09000064804af151 | ||||
| FDA-2002-N-0034-0003 | FDA | Presiding Officers at Regulatory Hearings FDA-2002-N-0034 | Presiding Officers at Regulatory Hearings; Confirmation of Effective Date | Rule | Confirmation of Effective Date | 2002-12-11T05:00:00Z | 2002 | 12 | 2002-12-02T05:00:00Z | 2025-05-06T16:45:50Z | 02-30483 | 0 | 0 | 090000648048af46 | |
| FDA-2002-D-0174-0001 | FDA | Guidance regarding the use of the term "Catfish" FDA-2002-D-0174 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-10T05:00:00Z | 2002 | 12 | 2008-04-12T01:17:11Z | 0 | 0 | 0900006480494cc4 | |||
| FDA-2001-N-0178-0001 | FDA | Performance Standard for Diagnostic X-Ray Systems and Their Major Components FDA-2001-N-0178 | Electronic Products; Performance Standard for Diagnostic X-Ray Systems and Their Major Components | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2002-12-10T05:00:00Z | 2002 | 12 | 2002-12-10T05:00:00Z | 2003-04-10T03:59:59Z | 2016-02-03T22:01:16Z | 0 | 0 | 09000064804e1548 | |
| FDA-1997-N-0047-0001 | FDA | Labeling of Diphenhydramine-Containing Drug Products OTC FDA-1997-N-0047 | Labeling of Diphenhydramine- Containing Drug Products for Over-the-Counter Human Use | Notice | Notice of Final Rule | 2002-12-10T00:00:00Z | 2002 | 12 | 2002-12-06T05:00:00Z | 2025-05-14T18:55:05Z | 02-30641 | 0 | 0 | 09000064805cfc95 | |
| FDA-2002-P-0129-0003 | FDA | ANDAs Relaying Permax As Reference Listed Drug Not Be Approved-CLOSED FDA-2002-P-0129 | FDA/CDER to Amarin Pharmaceuticals, Inc. | Other | PDN-Petition Denial | 2002-12-06T05:00:00Z | 2002 | 12 | 2008-04-12T01:26:43Z | 0 | 0 | 09000064804905e5 | |||
| FDA-2002-P-0259-0002 | FDA | Make determination of ANDA suitability for Amiodarone Hydroc-CLOSED FDA-2002-P-0259 | FDA/CDER to Taro Research Institute Ltd. | Other | PAV-Petition Approval | 2002-12-06T05:00:00Z | 2002 | 12 | 2008-04-12T01:27:57Z | 0 | 0 | 090000648049c57d | |||
| FDA-2002-P-0166-0002 | FDA | ANDA Suitability for Clozapine 50 mg Tablets-CLOSED FDA-2002-P-0166 | FDA/CDER to AAC Consulting Group | Other | PAV-Petition Approval | 2002-12-06T05:00:00Z | 2002 | 12 | 2008-04-12T01:26:53Z | 0 | 0 | 09000064804945df | |||
| FDA-2002-P-0173-0002 | FDA | ANDA for amoxicillin tabs for oral suspension 300 & 600mg-CLOSED FDA-2002-P-0173 | FDA/CDER to The Weinberg Group Inc. | Other | PAV-Petition Approval | 2002-12-06T05:00:00Z | 2002 | 12 | 2008-04-12T01:27:00Z | 0 | 0 | 0900006480494c28 | |||
| FDA-1994-D-0007-0001 | FDA | Utility Study Anti-Salmonella Chemical Food Adds in Feeds FDA-1994-D-0007 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-04T05:00:00Z | 2002 | 12 | 2008-05-16T23:11:39Z | 0 | 0 | 09000064804fc5c9 | |||
| FDA-2002-N-0031-0002 | FDA | Animal Proteins Prohibited in Ruminant Feed FDA-2002-N-0031 | Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed; Correction | Notice | NCR-Notice of Correction | 2002-12-04T05:00:00Z | 2002 | 12 | 2008-04-23T19:52:47Z | 0 | 0 | 09000064804896b9 | |||
| FDA-2002-N-0100-0001 | FDA | Bavarian Red Cross: Revocation of U.S License No. 1002 FDA-2002-N-0100 | Bavarian Red Cross; Revocation of U.S. License No. 1002 | Notice | General Notice | 2002-12-04T05:00:00Z | 2002 | 12 | 2002-12-03T05:00:00Z | 2025-05-13T10:01:03Z | 02-30642 | 0 | 0 | 090000648048e8f7 | |
| FDA-2001-D-0031-0001 | FDA | Filth from Insects,Rodents & other Pests in Food FDA-2001-D-0031 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-04T05:00:00Z | 2002 | 12 | 2008-04-25T02:24:47Z | 0 | 0 | 09000064804b6188 | |||
| FDA-2002-N-0026-0003 | FDA | Veterinary Feed Directive (VFD)Information Collection Activi FDA-2002-N-0026 | Agency Information Collection Activities; Announcement of OMB Approval; Veterinary Feed Directive | Notice | Notice of Approval | 2002-12-04T05:00:00Z | 2002 | 12 | 2002-12-03T05:00:00Z | 2025-04-30T16:49:41Z | 02-30643 | 0 | 0 | 09000064804891bc | |
| FDA-1990-N-0008-0001 | FDA | Parenteral Drug Prod. Containing Aluminum as an Ingredient FDA-1990-N-0008 | FDA | Notice | NFR-Notice of Final Rule | 2002-12-04T05:00:00Z | 2002 | 12 | 2008-05-16T23:47:47Z | 0 | 0 | 09000064805287c2 | |||
| FDA-2002-N-0231-0003 | FDA | Focus Groups as used by the Food and Drug Administration FDA-2002-N-0231 | Agency Information Collection Activities; Announcement of OMB Approval; Focus Groups as Used by the Food and Drug Administration | Notice | Notice of Approval | 2002-12-03T05:00:00Z | 2002 | 12 | 2002-11-26T05:00:00Z | 2025-05-01T19:16:03Z | 02-29927 | 0 | 0 | 0900006480497a33 | |
| FDA-2002-N-0060-0001 | FDA | Prescription Drug Marketing Act of 1987 FDA-2002-N-0060 | Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug Marketing Act of 1987 | Notice | General Notice | 2002-12-03T05:00:00Z | 2002 | 12 | 2002-12-02T05:00:00Z | 2003-02-01T04:59:59Z | 2025-05-13T10:06:39Z | 02-30404 | 0 | 0 | 090000648048bfc7 |
| FDA-2002-N-0324-0001 | FDA | Withdrawal of 20 Guidances on Individual Product Labeling FDA-2002-N-0324 | Withdrawal of 20 Guidances on Individual Product Labeling | Notice | Withdrawal | 2002-12-03T05:00:00Z | 2002 | 12 | 2002-12-02T05:00:00Z | 2025-05-13T09:33:29Z | 02-30481 | 0 | 0 | 09000064804a0b63 | |
| FDA-2002-D-0086-0001 | FDA | Blood products safety cases known/suspected West Nile Virus FDA-2002-D-0086 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-02T05:00:00Z | 2002 | 12 | 2008-04-12T01:16:24Z | 0 | 0 | 090000648048dd7b | |||
| FDA-2002-D-0086-0002 | FDA | Blood products safety cases known/suspected West Nile Virus FDA-2002-D-0086 | FDA | Notice | NAD-Notice of Availability of Data | 2002-12-02T05:00:00Z | 2002 | 12 | 2008-04-12T01:16:24Z | 0 | 0 | 090000648048ddb1 | |||
| FDA-2001-N-0100-0002 | FDA | Medical Washer & Medical Washer-Disinfector FDA-2001-N-0100 | Medical Devices; Classification for Medical Washer and Medical Washer-Disinfector | Notice | Notice of Final Rule | 2002-12-02T05:00:00Z | 2002 | 12 | 2025-01-29T15:34:40Z | 02-28942 | 0 | 0 | 09000064804ba8f6 | ||
| FDA-2002-N-0027-0002 | FDA | Objections & Request for a Hearing on a Regulation or Order FDA-2002-N-0027 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; Filing Objections and Requests for a Hearing on a Regulation or Order | Notice | General Notice | 2002-12-01T05:00:00Z | 2002 | 12 | 2002-11-29T05:00:00Z | 2002-12-31T04:59:59Z | 2025-05-07T21:56:53Z | 02-30157 | 0 | 0 | 0900006480489273 |
| FDA-1976-N-0027-0008 | FDA | OTC Nasal Decongestants FDA-1976-N-0027 | Letter from FDA/CDER to Bayer Corporation | Other | Letter(s) | 2002-11-27T05:00:00Z | 2002 | 11 | 2015-10-29T19:49:11Z | 0 | 0 | 090000648051b762 | |||
| FDA-1999-N-0036-0002 | FDA | Food Contact Substance Notification System FDA-1999-N-0036 | Notice of Approval re Agency Information Collection Activities; Announcement of OMB Approval; Food Contact Substances Notification System | Notice | Notice of Approval | 2002-11-26T05:00:00Z | 2002 | 11 | 2002-11-22T05:00:00Z | 2024-10-04T21:50:22Z | 67FR35724 | 0 | 0 | 09000064804a5d6a | |
| FDA-2002-D-0178-0001 | FDA | Transcutaneous Air Conduction Hearing Aid System FDA-2002-D-0178 | FDA | Notice | NAD-Notice of Availability of Data | 2002-11-25T05:00:00Z | 2002 | 11 | 2002-11-25T05:00:00Z | 2003-02-06T04:59:59Z | 2008-04-12T01:17:15Z | 0 | 0 | 09000064804950f0 | |
| FDA-1994-P-0041-0004 | FDA | Require Labeling of Trans Fatty Acid & Prohibit Deceptive Claims-CLOSED FDA-1994-P-0041 | FDA | Notice | NEC-Notice of Extension | 2002-11-21T05:00:00Z | 2002 | 11 | 2002-11-21T05:00:00Z | 2002-12-17T04:59:59Z | 2008-05-16T23:20:31Z | 0 | 0 | 09000064804febbe | |
| FDA-2001-E-0052-0001 | FDA | Patent Term Extension Application, Evoxac No. 4,855,290 FDA-2001-E-0052 | FDA | Notice | N-Notice | 2002-11-20T05:00:00Z | 2002 | 11 | 2008-04-25T02:25:47Z | 0 | 0 | 09000064804b7e12 | |||
| FDA-2002-N-0195-0001 | FDA | Blood Establishment Registration/Product Listing,formFDA2830 FDA-2002-N-0195 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; Blood Establishment Registration and Product Listing, Form FDA 2830 | Notice | General Notice | 2002-11-20T05:00:00Z | 2002 | 11 | 2002-11-19T05:00:00Z | 2002-12-20T04:59:59Z | 2025-05-08T23:20:38Z | 02-29295 | 0 | 0 | 09000064804958a1 |
| FDA-2002-E-0039-0001 | FDA | Patent Term Application for Gleevac No. 5,521,184 FDA-2002-E-0039 | Determination of Regulatory Review Period for Purposes of Patent Extension; GLEEVEC | Notice | General Notice | 2002-11-20T05:00:00Z | 2002 | 11 | 2002-11-18T05:00:00Z | 2025-09-30T23:40:55Z | 02-29187 | 0 | 0 | 090000648048b33a | |
| FDA-2002-P-0164-0002 | FDA | Refrain from Approving ANDA for Isotretinoin Drug Products - CLOSED FDA-2002-P-0164 | FDA/CDER to Covington & Burling - Petition Approval | Other | PAV-Petition Approval | 2002-11-15T05:00:00Z | 2002 | 11 | 2012-07-11T22:03:47Z | 0 | 0 | 090000648049444d | |||
| FDA-2000-N-0008-0002 | FDA | Proposal to Debar Elaine Yee-Ling Lai:Notice of Opportunity FDA-2000-N-0008 | Elaine Yee-Ling Lai; Debarment Order | Notice | General Notice | 2002-11-14T05:00:00Z | 2002 | 11 | 2002-11-13T05:00:00Z | 2025-06-13T00:17:48Z | 02-28715 | 0 | 0 | 09000064804ae686 | |
| FDA-2000-N-0008-0001 | FDA | Proposal to Debar Elaine Yee-Ling Lai:Notice of Opportunity FDA-2000-N-0008 | Elaine Yee-Ling Lai; Debarment Order | Notice | General Notice | 2002-11-14T05:00:00Z | 2002 | 11 | 2002-11-13T05:00:00Z | 2025-06-13T00:17:12Z | 02-28715 | 0 | 0 | 09000064804ae680 | |
| FDA-2001-E-0148-0001 | FDA | Argatroban, Patent Extension Application No.5,214,052 FDA-2001-E-0148 | Determination of Regulatory Review Period for Purposes of Patent Extension; ACOVA | Notice | General Notice | 2002-11-14T05:00:00Z | 2002 | 11 | 2002-11-14T05:00:00Z | 2003-01-14T04:59:59Z | 2025-10-10T00:02:57Z | 0 | 0 | 09000064804ddc99 | |
| FDA-2001-E-0233-0001 | FDA | Calozal, Patent Extension Application No. 4,412,992 FDA-2001-E-0233 | Determination of Regulatory Review Period for Purposes of Patent Extension; COLAZAL | Notice | General Notice | 2002-11-14T05:00:00Z | 2002 | 11 | 2002-11-14T05:00:00Z | 2003-01-14T04:59:59Z | 2025-10-20T22:55:24Z | 0 | 0 | 09000064804e6151 | |
| FDA-2001-E-0149-0001 | FDA | Patent Term Extension Application for Lotronex No. 5,360,800 FDA-2001-E-0149 | FDA | Notice | N-Notice | 2002-11-14T05:00:00Z | 2002 | 11 | 2002-11-14T05:00:00Z | 2003-01-14T04:59:59Z | 2008-04-25T02:26:25Z | 0 | 0 | 09000064804ddcba | |
| FDA-2002-E-0336-0001 | FDA | Patent Term Application for Solage No. 5,194,247 FDA-2002-E-0336 | Determination of Regulatory Review Period for Purposes of Patent Extension; SOLAGE | Notice | General Notice | 2002-11-14T05:00:00Z | 2002 | 11 | 2002-11-14T05:00:00Z | 2003-01-14T04:59:59Z | 2025-09-30T19:27:12Z | 02-28885 | 0 | 0 | 09000064804a0ca4 |
| FDA-2002-M-0038-0001 | FDA | PMA Contak CD CRT-D System & EASYTRAK Coronary Venous Steroi FDA-2002-M-0038 | FDA | Notice | N-Notice | 2002-11-13T05:00:00Z | 2002 | 11 | 2008-04-12T01:19:22Z | 0 | 0 | 090000648048b24e | |||
| FDA-2002-P-0083-0002 | FDA | Physical form of drug product in to a oral liquid generic-CLOSED FDA-2002-P-0083 | FDA/CVM to Phoenix Scientific, Inc. | Other | PAV-Petition Approval | 2002-11-13T05:00:00Z | 2002 | 11 | 2008-04-12T01:26:33Z | 0 | 0 | 090000648048da81 | |||
| FDA-2002-M-0282-0001 | FDA | Model AC21B UV-Absorb'g PMMA Anterior Chamber Intraocular Le FDA-2002-M-0282 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-19T00:29:49Z | 02-28155 | 0 | 0 | 090000648049e990 | ||
| FDA-2002-M-0241-0001 | FDA | PMA QuantiFERON-tb, P010033 FDA-2002-M-0241 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-21T17:44:48Z | 02-28155 | 0 | 0 | 090000648049a505 | ||
| FDA-2002-M-0067-0001 | FDA | PMA On-X Prosthetic Heart Valve, Models ONXM & ONXMC FDA-2002-M-0067 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-21T21:10:50Z | 02-28551 | 0 | 0 | 090000648048c83f | ||
| FDA-2002-M-0330-0001 | FDA | Amplatzer PFO Occuluder, H000007 FDA-2002-M-0330 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-13T18:05:29Z | 02-28155 | 0 | 0 | 09000064804a0be3 | ||
| FDA-2002-N-0194-0001 | FDA | Effectiveness of New Drugs When Human Efficacy Studies FDA-2002-N-0194 | Agency Information Collection Activities; Proposed Collection; Comment Request; New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible | Notice | General Notice | 2002-11-13T05:00:00Z | 2002 | 11 | 2002-11-13T05:00:00Z | 2003-01-14T04:59:59Z | 2025-05-13T09:43:12Z | 02-28854 | 0 | 0 | 090000648049588f |
| FDA-2002-M-0239-0001 | FDA | P010018; ViewPoint CK System FDA-2002-M-0239 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-13T00:09:32Z | 02-28155 | 0 | 0 | 090000648049a328 | ||
| FDA-2002-M-0333-0001 | FDA | PMA IntraCoil Self-expanding Peripheral Stent, P000033 FDA-2002-M-0333 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-21T19:20:19Z | 02-28155 | 0 | 0 | 09000064804a0bff | ||
| FDA-2002-M-0203-0001 | FDA | P000049; CardioSEAL Septal Occlusion System with QwikLoad FDA-2002-M-0203 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-21T22:27:10Z | 02-28155 | 0 | 0 | 0900006480495f5c | ||
| FDA-2002-P-0068-0001 | FDA | Classification of Transscutaneous Air Conduction Hearing Aid FDA-2002-P-0068 | FDA - Notice of Final Rule | Notice | NFR-Notice of Final Rule | 2002-11-13T05:00:00Z | 2002 | 11 | 2009-03-16T18:16:16Z | 0 | 0 | 090000648048c93e | |||
| FDA-2002-D-0147-0001 | FDA | The Administrative New Animal Drug Application Process FDA-2002-D-0147 | FDA | Notice | NAD-Notice of Availability of Data | 2002-11-13T05:00:00Z | 2002 | 11 | 2002-11-13T05:00:00Z | 2003-01-22T04:59:59Z | 2008-04-12T01:17:07Z | 0 | 0 | 0900006480492511 | |
| FDA-2002-M-0202-0001 | FDA | P900033/S008; Dermal Regeneration Template FDA-2002-M-0202 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-19T01:15:59Z | 02-28155 | 0 | 0 | 0900006480495e9f | ||
| FDA-2002-M-0158-0001 | FDA | WALLSTENT Venous Endoprosthesis w/Unistep Plus RP Delivery FDA-2002-M-0158 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-19T01:02:10Z | 02-28155 | 0 | 0 | 0900006480493e69 | ||
| FDA-2002-M-0117-0001 | FDA | Medtronic Activa Parkinson's Control Therapy, P960009/s0007 FDA-2002-M-0117 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-21T01:17:33Z | 02-28155 | 0 | 0 | 09000064804900c6 | ||
| FDA-2002-P-0215-0002 | FDA | ANADA for ivermectin having a different dosage form-CLOSED FDA-2002-P-0215 | FDA/CDRH to Richdel, Inc. | Other | PAV-Petition Approval | 2002-11-13T05:00:00Z | 2002 | 11 | 2008-04-12T01:27:11Z | 0 | 0 | 0900006480496a8f | |||
| FDA-2002-M-0201-0001 | FDA | P010025; Lorad Digital Breast Imager (LDBI) FDA-2002-M-0201 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-12T23:51:01Z | 02-28155 | 0 | 0 | 0900006480495dc4 | ||
| FDA-2002-N-0275-0002 | FDA | Medical Device Recall Authority;Agency Information Collectio FDA-2002-N-0275 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; Medical Device Recall Authority | Notice | General Notice | 2002-11-13T05:00:00Z | 2002 | 11 | 2002-11-13T05:00:00Z | 2002-12-14T04:59:59Z | 2025-05-13T02:28:19Z | 02-28713 | 0 | 0 | 090000648049e491 |
| FDA-2002-M-0334-0001 | FDA | PMA LAP-Band Adjustable Gastric Banding (LAGB) System FDA-2002-M-0334 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-21T19:57:09Z | 02-28155 | 0 | 0 | 09000064804a0c0d | ||
| FDA-2002-M-0037-0001 | FDA | P010030; WCD 2000 System FDA-2002-M-0037 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-25T17:19:16Z | 02-28155 | 0 | 0 | 090000648048b183 | ||
| FDA-2002-M-0281-0001 | FDA | PMA VISX Excimer Laser System & Custome Contoured Ablation FDA-2002-M-0281 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-26T18:24:54Z | 02-28155 | 0 | 0 | 090000648049e8e7 | ||
| FDA-2002-N-0031-0001 | FDA | Animal Proteins Prohibited in Ruminant Feed FDA-2002-N-0031 | Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed | Proposed Rule | NPR-Notice of Proposed Rule-Making | 2002-11-13T05:00:00Z | 2002 | 11 | 2002-11-05T05:00:00Z | 2003-02-05T04:59:59Z | 2009-04-11T07:00:02Z | 0 | 0 | 090000648048956c | |
| FDA-2002-P-0254-0002 | FDA | ANADA for a generic version of trimethoprim & sulfadiazine c-CLOSED FDA-2002-P-0254 | FDA/DDM to Pharmaceutical Solutions, Inc | Other | PAV-Petition Approval | 2002-11-13T05:00:00Z | 2002 | 11 | 2008-04-12T01:27:53Z | 0 | 0 | 090000648049c210 | |||
| FDA-2001-P-0215-0001 | FDA | Determine whether Sotradecol has been withdrawn from sale in FDA-2001-P-0215 | FDA | Notice | N-Notice | 2002-11-13T05:00:00Z | 2002 | 11 | 2024-08-12T20:41:36Z | 0 | 0 | 09000064804e4832 | |||
| FDA-2002-M-0157-0001 | FDA | P010054; Elecsys Anti-HBs Immunoassay & Elecsys PreciControl FDA-2002-M-0157 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-13T01:24:22Z | 02-28155 | 0 | 0 | 0900006480493dc2 | ||
| FDA-2002-M-0204-0001 | FDA | P980024/S001; PathVysion HER-2 DNA Probe Kit FDA-2002-M-0204 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-12T23:02:47Z | 02-28155 | 0 | 0 | 0900006480496029 | ||
| FDA-2002-M-0280-0001 | FDA | P000039; AMPLATZER Septal Occluder (ASO) & Exchange System FDA-2002-M-0280 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Data Availability | 2002-11-13T05:00:00Z | 2002 | 11 | 2025-08-21T22:11:23Z | 02-28155 | 0 | 0 | 090000648049e834 | ||
| FDA-2000-D-0032-0001 | FDA | Electronic Signatures, Electronic Copies of Electronic Records FDA-2000-D-0032 | FDA | Notice | NAD-Notice of Availability of Data | 2002-11-12T05:00:00Z | 2002 | 11 | 2002-11-12T05:00:00Z | 2003-02-11T04:59:59Z | 2008-04-25T01:12:51Z | 0 | 0 | 09000064804aed2a | |
| FDA-2002-D-0021-0002 | FDA | Intraoral Devices for Snoring/Obstructive Sleep Apnea FDA-2002-D-0021 | FDA | Notice | NAD-Notice of Availability of Data | 2002-11-12T05:00:00Z | 2002 | 11 | 2002-11-12T05:00:00Z | 2003-11-14T04:59:59Z | 2008-04-12T01:16:12Z | 0 | 0 | 0900006480488d1e |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);